EXPLORING THE UNKNOWN: USE OF SENSITIVITY ANALYSIS TO CHARACTERIZE RESIDUAL UNCERTAINTY IN REAL-WORLD EXTERNAL CONTROL ARM EVIDENCE SUBMITTED TO NICE

被引：0
|
作者：
Leahy, T. [1 ]
Keenan, C. [1 ]
Robertshaw, E. [1 ]
Mcstravick, M. [2 ]
Sammon, C. [1 ]
Turner, A. [1 ]
机构：
[1] Putnam Associates, London, England
[2] Putnam Associates, Newcastle Upon Tyne, England
来源：
VALUE IN HEALTH | 2024年 / 27卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
P2
引用
收藏
页数：2
相关论文
共 50 条
  • [1] INFLUENCE OF REAL-WORLD EVIDENCE TO SUPPORT SINGLE ARM TRIALS SUBMITTED TO NICE FOR ORPHAN ONCOLOGY PRODUCTS
    Falla, E.
    Gaultney, J.
    VALUE IN HEALTH, 2022, 25 (01) : S179 - S179
  • [2] Real-world evidence use in assessments of cancer drugs by NICE
    Bullement, Ash
    Podkonjak, Tanja
    Robinson, Mark J.
    Benson, Eugene
    Selby, Ross
    Hatswell, Anthony J.
    Shields, Gemma E.
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2020, 36 (04) : 388 - 394
  • [3] PMDA Perspective on Use of Real-World Data and Real-World Evidence as an External Control: Recent Examples and Considerations
    Asano, Junichi
    Sugano, Hiromi
    Murakami, Hiroyuki
    Noguchi, Atsushi
    Ando, Yuki
    Uyama, Yoshiaki
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2025,
  • [4] THE USE OF PUBLISHED REAL-WORLD EVIDENCE IN HTA: AN ANALYSIS OF THE EVIDENCE BASE OF COMPANY SUBMISSIONS IN 2016 NICE APPRAISALS
    Van Lier, H.
    de Boeck, M.
    Edwards, V
    Hanekamp, E.
    Hartog, T. E.
    Richmond, G.
    van den Broek, R.
    VALUE IN HEALTH, 2017, 20 (09) : A410 - A410
  • [5] APPLICATION OF META-ANALYSIS APPROACH TO DEVELOP AN EXTERNAL CONTROL ARM IN ONCOLOGY AND RARE DISEASES: INSIGHTS FROM REAL-WORLD EVIDENCE
    Gona, O. J.
    Kumar, A.
    Noone, G.
    Sinha, S.
    VALUE IN HEALTH, 2022, 25 (12) : S487 - S487
  • [6] Use of quantitative bias analysis to evaluate single-arm trials with real-world data external controls
    Gray, Christen
    Ralphs, Eleanor
    Fox, Matthew P.
    Lash, Timothy L.
    Liu, Geoffrey
    Kou, Tzuyung Doug
    Rivera, Donna R.
    Bosco, Jaclyn
    Braun, Kim Van Naarden
    Grimson, Fiona
    Layton, Deborah
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 (05)
  • [7] THE USE OF REAL-WORLD EVIDENCE IN NICE HEALTH TECHNOLOGY APPRAISALS: A QUANTITATIVE REVIEW OF SUBMISSIONS TO NICE BETWEEN 2022 AND 2024
    Aidarous, A.
    Tahir, H.
    Diribe, O.
    Allen, R.
    VALUE IN HEALTH, 2024, 27 (12) : S358 - S358
  • [8] Design and Evaluation of an External Control Arm Using Prior Clinical Trials and Real-World Data
    Ventz, Steffen
    Lai, Albert
    Cloughesy, Timothy F.
    Wen, Patrick Y.
    Trippa, Lorenzo
    Alexander, Brian M.
    CLINICAL CANCER RESEARCH, 2019, 25 (16) : 4993 - 5001
  • [9] COMPARISON OF THE USE OF REAL-WORLD EVIDENCE FOR CLINICAL EFFECTIVENESS IN HTA PRE- AND POSTINTRODUCTION OF THE NICE FRAMEWORK
    Mackley, R.
    Green, R.
    Shrivastava, M.
    Chasimpha, S.
    Teague, R.
    VALUE IN HEALTH, 2023, 26 (12) : S390 - S391
  • [10] A SYSTEMATIC LITERATURE REVIEW ON THE USE OF REAL-WORLD EVIDENCE IN NICE TECHNOLOGY APPRAISALS INDICATED FOR MULTIPLE MYELOMA
    Dempsey, J.
    Tsang, C.
    Duffield, C.
    VALUE IN HEALTH, 2023, 26 (12) : S520 - S520
12345